CD8A and esophageal cancer: For example, CAFs increase the ratio of FoxP3+ (Tregs) and CD8+ tumor-infiltrating lymphocytes via IL-6 in TME, and IL-6 blockade enhances the immunotherapy efficacy in esophageal cancer models (127).